NCT02101476View on ClinicalTrials.gov

An Open Label, Prospective Study of the Analgesic Efficacy of Oral Xartemis Compared to Generic Oxycodone/APAP( Acetaminophen) in the Treatment of Moderate to Severe Post Operative Pain.

PHASE4CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

October 31, 2014

Conditions
Post Operative Pain
Interventions
DRUG

Percocet

10mg/650mg

DRUG

Xartemis

15mg/650mg

Trial Locations (1)

91105

Lotus Clinical Resarch,LLC, Pasadena

Sponsors

Collaborators (1)

Mallinckrodt
All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

lead

Lotus Clinical Research, LLC

OTHER

NCT02101476 - An Open Label, Prospective Study of the Analgesic Efficacy of Oral Xartemis Compared to Generic Oxycodone/APAP( Acetaminophen) in the Treatment of Moderate to Severe Post Operative Pain. | Biotech Hunter | Biotech Hunter